
TY  - JOUR
TI  - SIOP Abstracts
JO  - Medical and Pediatric Oncology
JA  - Med. Pediatr. Oncol.
VL  - 41
IS  - 4
SN  - 0098-1532
UR  - https://doi.org/10.1002/mpo.10407
DO  - doi:10.1002/mpo.10407
SP  - 245
EP  - 398
PY  - 2003
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 16
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2010.03239.x
DO  - doi:10.1111/j.1469-0691.2010.03239.x
SP  - S133
EP  - S634
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2004 SAEM ANNUAL MEETING ABSTRACTS
JO  - Academic Emergency Medicine
VL  - 11
IS  - 5
SN  - 1069-6563
UR  - https://doi.org/10.1197/j.aem.2004.02.011
DO  - doi:10.1197/j.aem.2004.02.011
SP  - 435
EP  - 607
PY  - 2004
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 122
IS  - S1
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.13370
DO  - doi:10.1111/1471-0528.13370
SP  - 157
EP  - 234
PY  - 2015
ER  - 

TY  - JOUR
TI  - ACVIM ABSTRACTS
JO  - Journal of Veterinary Internal Medicine
VL  - 13
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1999.tb02182.x
DO  - doi:10.1111/j.1939-1676.1999.tb02182.x
SP  - 217
EP  - 287
PY  - 1999
ER  - 

TY  - JOUR
TI  - 22nd Clinical Congress Abstracts
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 22
IS  - 1
SN  - 0148-6071
UR  - https://doi.org/10.1177/014860719802200110
DO  - doi:10.1177/014860719802200110
SP  - S1
EP  - S21
PY  - 1998
ER  - 

TY  - JOUR
TI  - Poster Communications
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 218
IS  - S709
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.12779
DO  - doi:10.1111/apha.12779
SP  - 26
EP  - 91
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 50
IS  - S41
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23297
DO  - doi:10.1002/ppul.23297
SP  - S193
EP  - S453
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of the 29th annual meeting of the human biology association Tampa, Florida April 14-15, 2004
JO  - American Journal of Human Biology
JA  - Am. J. Hum. Biol.
VL  - 16
IS  - 2
SN  - 1042-0533
UR  - https://doi.org/10.1002/ajhb.20013
DO  - doi:10.1002/ajhb.20013
SP  - 194
EP  - 231
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster - Gastroenterology
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 30
IS  - S4
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.13188
DO  - doi:10.1111/jgh.13188
SP  - 28
EP  - 159
PY  - 2015
ER  - 

C7  - pp. 413-452
TI  - Index
SN  - 9781118758243
UR  - https://doi.org/10.1002/9781119080343.index
DO  - doi:10.1002/9781119080343.index
SP  - 413-452
PY  - 2015
AB  - Abstract No Abstract.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 17
IS  - s1
SN  - 9781118758243
UR  - https://doi.org/10.1111/1756-185x.12344
DO  - doi:10.1111/1756-185x.12344
SP  - 1
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
AU  - Dávalos, Alberto
AU  - Henriques, Rossana
AU  - Latasa, María Jesús
AU  - Laparra, Moisés
AU  - Coca, María
C7  - 1688E
TI  - Literature review of baseline information on non-coding RNA (ncRNA) to support the risk assessment of ncRNA-based genetically modified plants for food and feed
JO  - EFSA Supporting Publications
JA  - EFSA Supporting Publications
VL  - 16
IS  - 8
SN  - 9781118758243
UR  - https://doi.org/10.2903/sp.efsa.2019.EN-1688
DO  - doi:10.2903/sp.efsa.2019.EN-1688
SP  - 1688E
PY  - 2019
AB  - This report is the outcome of an EFSA procurement (NP/EFSA/GMO/2016/01) reviewing relevant scientific information on ncRNA and on RNA interference(RNAi) that could support the food and feed risk assessment of ncRNA-based genetically modified (GM) plants. Information was retrieved through key words and key questions covering the stability and degradation of ncRNAs after oral ingestion, the passage of ncRNAs from food and feed to human and animal organs and tissues via the gastrointestinal tract and other barriers, as well as the potential effects on the gastrointestinal tract, the immune system or the entire organism.Full description of the strategy used for the literature search and for studies selectionis provided and the number of retrieved publications is reported. This report is divided into four partsdiscussing the kinetics of exogenous ncRNAs in humans and animals, with focus on ingested ncRNAs (Part 1); the possible effects of ncRNAs on the gastrointestinal tract (Part 2), systemically(Part 3)and on the immune system (Part 4). This report suggests that some plant ncRNAs (e.g miRNAs and siRNAs) show higher stability as compared to other ncRNAs due to peculiar chemical characteristics (2?-O-methylation at 3? end).However, ingested or administered ncRNA must overcome many extracellular and cellular barriers to reach the intended target tissue or functional location in sufficient amount to exert any biological effect. Literature data indicate that chemically unmodified and unformulated ncRNAs exhibit very low stability in the gastrointestinal tract and in biological fluids and, in general, do not elicit major biological effects.This report also provides an overview of the RNA content in plant-derived foods and diets and discusses the controversies on the presence of dietary exogenous RNAs in the biological fluids of humans and animals and their effects. Finally, gaps in the scientific literature are highlighted and recommendations provided
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Clinical Microbiology and Infection
VL  - 18
IS  - s3
SN  - 9781118758243
UR  - https://doi.org/10.1111/j.1469-0691.2012.03802.x
DO  - doi:10.1111/j.1469-0691.2012.03802.x
SP  - 114
EP  - 715
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
VL  - 7
IS  - s1
SN  - 9781118758243
UR  - https://doi.org/10.1111/j.1463-1318.2005.00844.x
DO  - doi:10.1111/j.1463-1318.2005.00844.x
SP  - 45
EP  - 143
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - The Journal of Dermatology
JA  - J Dermatol
VL  - 41
IS  - s1
SN  - 9781118758243
UR  - https://doi.org/10.1111/1346-8138.12686
DO  - doi:10.1111/1346-8138.12686
SP  - 17
EP  - 114
PY  - 2014
ER  - 

TY  - JOUR
AU  - Girotti, Alessandra
AU  - Orbanic, Doriana
AU  - Ibáñez-Fonseca, Arturo
AU  - Gonzalez-Obeso, Constancio
AU  - Rodríguez-Cabello, José Carlos
TI  - Recombinant Technology in the Development of Materials and Systems for Soft-Tissue Repair
JO  - Advanced Healthcare Materials
JA  - Adv. Healthcare Mater.
VL  - 4
IS  - 16
SN  - 9781118758243
UR  - https://doi.org/10.1002/adhm.201500152
DO  - doi:10.1002/adhm.201500152
SP  - 2423
EP  - 2455
KW  - recombinant-protein biomaterials
KW  - elastin
KW  - silk
KW  - collagen
KW  - resilin
PY  - 2015
AB  - The field of biomedicine is constantly investing significant research efforts in order to gain a more in-depth understanding of the mechanisms that govern the function of body compartments and to develop creative solutions for the repair and regeneration of damaged tissues. The main overall goal is to develop relatively simple systems that are able to mimic naturally occurring constructs and can therefore be used in regenerative medicine. Recombinant technology, which is widely used to obtain new tailored synthetic genes that express polymeric protein-based structures, now offers a broad range of advantages for that purpose by permitting the tuning of biological and mechanical properties depending on the intended application while simultaneously ensuring adequate biocompatibility and biodegradability of the scaffold formed by the polymers. This Progress Report is focused on recombinant protein-based materials that resemble naturally occurring proteins of interest for use in soft tissue repair. An overview of recombinant biomaterials derived from elastin, silk, collagen and resilin is given, along with a description of their characteristics and suggested applications. Current endeavors in this field are continuously providing more-improved materials in comparison with conventional ones. As such, a great effort is being made to put these materials through clinical trials in order to favor their future use.
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Clinical Microbiology and Infection
VL  - 16
IS  - s2
SN  - 9781118758243
UR  - https://doi.org/10.1111/j.1469-0691.2010.03238.x
DO  - doi:10.1111/j.1469-0691.2010.03238.x
SP  - S1
EP  - S132
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Internal Medicine Journal
VL  - 40
IS  - s1
SN  - 9781118758243
UR  - https://doi.org/10.1111/j.1445-5994.2010.02186.x
DO  - doi:10.1111/j.1445-5994.2010.02186.x
SP  - 1
EP  - 65
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Pathology International
VL  - 54
IS  - s2
SN  - 9781118758243
UR  - https://doi.org/10.1111/j.1440-1827.2004.01762.x
DO  - doi:10.1111/j.1440-1827.2004.01762.x
SP  - A1
EP  - A37
PY  - 2004
ER  - 
